Bespalov MM[au] - Search Results

Year	Number of Results
1996	1
1997	1
2000	2
2004	1
2005	1
2007	1
2008	3
2009	1
2010	1
2011	1
2013	2
2016	2
2017	2
2019	2
2020	1
2024	0

1

GDNF family receptor complexes are emerging drug targets.

Bespalov MM, Saarma M. Bespalov MM, et al. Trends Pharmacol Sci. 2007 Feb;28(2):68-74. doi: 10.1016/j.tips.2006.12.005. Epub 2007 Jan 10. Trends Pharmacol Sci. 2007. PMID: 17218019 Review.

2

Persephin signaling through GFRalpha1: the potential for the treatment of Parkinson's disease.

Sidorova YA, Mätlik K, Paveliev M, Lindahl M, Piranen E, Milbrandt J, Arumäe U, Saarma M, Bespalov MM. Sidorova YA, et al. Among authors: bespalov mm. Mol Cell Neurosci. 2010 Jul;44(3):223-32. doi: 10.1016/j.mcn.2010.03.009. Epub 2010 Mar 27. Mol Cell Neurosci. 2010. PMID: 20350599

3

Sensory neurons from N-syndecan-deficient mice are defective in survival.

Paveliev M, Hienola A, Jokitalo E, Planken A, Bespalov MM, Rauvala H, Saarma M. Paveliev M, et al. Among authors: bespalov mm. Neuroreport. 2008 Sep 17;19(14):1397-400. doi: 10.1097/WNR.0b013e32830d1486. Neuroreport. 2008. PMID: 18766019

4

Comparison of liquid chromatography-mass spectrometry and direct infusion microchip electrospray ionization mass spectrometry in global metabolomics of cell samples.

Pöhö P, Lipponen K, Bespalov MM, Sikanen T, Kotiaho T, Kostiainen R. Pöhö P, et al. Among authors: bespalov mm. Eur J Pharm Sci. 2019 Oct 1;138:104991. doi: 10.1016/j.ejps.2019.104991. Epub 2019 Aug 9. Eur J Pharm Sci. 2019. PMID: 31404622

5

Developing therapeutically more efficient Neurturin variants for treatment of Parkinson's disease.

Runeberg-Roos P, Piccinini E, Penttinen AM, Mätlik K, Heikkinen H, Kuure S, Bespalov MM, Peränen J, Garea-Rodríguez E, Fuchs E, Airavaara M, Kalkkinen N, Penn R, Saarma M. Runeberg-Roos P, et al. Among authors: bespalov mm. Neurobiol Dis. 2016 Dec;96:335-345. doi: 10.1016/j.nbd.2016.07.008. Epub 2016 Jul 15. Neurobiol Dis. 2016. PMID: 27425888

6

Glial cell line-derived neurotrophic factor receptor Rearranged during transfection agonist supports dopamine neurons in Vitro and enhances dopamine release In Vivo.

Mahato AK, Kopra J, Renko JM, Visnapuu T, Korhonen I, Pulkkinen N, Bespalov MM, Domanskyi A, Ronken E, Piepponen TP, Voutilainen MH, Tuominen RK, Karelson M, Sidorova YA, Saarma M. Mahato AK, et al. Among authors: bespalov mm. Mov Disord. 2020 Feb;35(2):245-255. doi: 10.1002/mds.27943. Epub 2019 Dec 16. Mov Disord. 2020. PMID: 31840869 Free PMC article.

7

Heparan sulfate proteoglycan syndecan-3 is a novel receptor for GDNF, neurturin, and artemin.

Bespalov MM, Sidorova YA, Tumova S, Ahonen-Bishopp A, Magalhães AC, Kulesskiy E, Paveliev M, Rivera C, Rauvala H, Saarma M. Bespalov MM, et al. J Cell Biol. 2011 Jan 10;192(1):153-69. doi: 10.1083/jcb.201009136. Epub 2011 Jan 3. J Cell Biol. 2011. PMID: 21200028 Free PMC article.

8

Bone morphogenetic protein-inducer tilorone identified by high-throughput screening is antifibrotic in vivo.

Leppäranta O, Tikkanen JM, Bespalov MM, Koli K, Myllärniemi M. Leppäranta O, et al. Among authors: bespalov mm. Am J Respir Cell Mol Biol. 2013 Apr;48(4):448-55. doi: 10.1165/rcmb.2012-0201OC. Am J Respir Cell Mol Biol. 2013. PMID: 23258233

9

Individualized systems medicine strategy to tailor treatments for patients with chemorefractory acute myeloid leukemia.

Pemovska T, Kontro M, Yadav B, Edgren H, Eldfors S, Szwajda A, Almusa H, Bespalov MM, Ellonen P, Elonen E, Gjertsen BT, Karjalainen R, Kulesskiy E, Lagström S, Lehto A, Lepistö M, Lundán T, Majumder MM, Marti JM, Mattila P, Murumägi A, Mustjoki S, Palva A, Parsons A, Pirttinen T, Rämet ME, Suvela M, Turunen L, Västrik I, Wolf M, Knowles J, Aittokallio T, Heckman CA, Porkka K, Kallioniemi O, Wennerberg K. Pemovska T, et al. Among authors: bespalov mm. Cancer Discov. 2013 Dec;3(12):1416-29. doi: 10.1158/2159-8290.CD-13-0350. Epub 2013 Sep 20. Cancer Discov. 2013. PMID: 24056683

10

Obatoclax, saliphenylhalamide and gemcitabine inhibit Zika virus infection in vitro and differentially affect cellular signaling, transcription and metabolism.

Kuivanen S, Bespalov MM, Nandania J, Ianevski A, Velagapudi V, De Brabander JK, Kainov DE, Vapalahti O. Kuivanen S, et al. Among authors: bespalov mm. Antiviral Res. 2017 Mar;139:117-128. doi: 10.1016/j.antiviral.2016.12.022. Epub 2016 Dec 31. Antiviral Res. 2017. PMID: 28049006

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

20 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year